Darabi S., Khaze, V., Riazi-Rad, F., Darabi, H., Bahrami, F., Ajdary, S. and Alimohammadian, M.H. 2015.

Leishmania majorstrains isolated from distinct endemic areas show diverse cytokine mRNA expression levels

in C57BL/6 mice: Toward selecting an ideal strain for the vaccine studies. Cytokine.S1043-4666(15)00208-2.

doi: 10.1016/j.cyto.2015.05.022. [Epub ahead of print].PMID: 26072430

Braganhol, E., Kukulski, F., Lévesque S.A., Fausther, M., Lavoie, E.G., Zanotto-Filho A., Bergamin, L.S.,

Pelletier, J., Bahrami, F., Ben Yebdri, F., Moreira, J.C., Battastini, A.M.O. and Sévigny, J. 2015. Nucleotide

receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells.

Biochimica et Biophysica Acta (Molecular Basis of Disease). 1852:120-130. PMID: 25445541

Bahrami, F., Kukulski, F., Lecka, J., Tremblay, A., Pelletier, J., Rockenbach, L. and Sévigny, J. 2014. Purine

metabolizing ectoenzymes control IL-8 production in human colon HT-29 cells. Mediators of Inflammation.

vol. 2014, Article ID 879895, 10 pages. doi:10.1155/2014/879895. PMID: 25242873

Bahrami, F., Darabi, H., Riazi-Rad, F., Khaze, V., Ajdary, S. and Alimohammadian, M.H. 2014.FOXP3

expression and frequency of regulatory T cells in healed individuals fromLeishmania majorinfection

and the asymptomatic cases. Human Immunology.75: 1026-1033. PMID: 25167770

Rafiee, A., Riazi-rad, F., Darabi, H., Khaze, V., Javadian, S., Ajdary, F., Bahrami, F. and Alimohammadian,

M.H. 2014. Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with

Leishmania major. International Journal of Pharmaceutics. 466: 375-381. PMID: 24657288

Kukulski, F., Bahrami, F., Ben Yebdri, F., Lecka, J., Martín-Satué, M., Lévesque, S.A., and Sévigny, J. 2011.

NTPDase1 Controls IL-8 Production by Human Neutrophils. The Journal of Immunology. 187: 644-653.

PMID: 21670316

Kukulski, F., Ben Yebdri, F., Bahrami, F., Fausther, F. Tremblay, A., and Sévigny, J. 2010. Endothelial P2Y2

receptor regulates LPS-induced neutrophil transendothelial migration in vitro. Molecular Immunology. 47: 991-

999. PMID: 20022380

Kukulski, F., Ben Yebdri, F., Bahrami, F., Lévesque, S., Martín-Satué, M., and Sévigny, J. 2010. The P2

receptor antagonist PPADS abrogates LPS-induced neutrophil migration in the murine air pouch via inhibition of

MIP-2 and KC production. Molecular Immunology. 47: 833-839. PMID: 19889460

Bahrami, F., and Jestin, J.L. 2008.Streptococcus agalactiaeDNA polymerase I is an efficient reverse

transcriptase. Biochimie. 90: 1796-1799. PMID: 18706966

Tremblay,Y.D.N., Bahrami, F., and Niven, D.F. 2006. Acquisition of haemoglobin bound iron byHistophilus

somni. Veterinary Microbiology. 114: 104-114. PMID: 16376031

Bahrami, F., and Niven, D.F. 2005. Iron acquisition byActinobacillus suis: identification and characterization of

a single-component haemoglobin receptor and encoding gene. Microbial Pathogenesis.39: 45-51.

PMID: 15899574

Ekins, A., Bahrami, F., Sijercic, A., Maret, D., and Niven, D.F. 2004.Haemophilus somnuspossesses two

systems for the acquisition of transferrin-bound iron

1- Jamnani FR, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudid F, Sharifzadeh Z,

T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumordirected

oligoclonal T cell therapy, Biochimica et Biophysica Acta, 2014, 1840(1): 378–386.

2- Sharifzadeh Z, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudid F, Jamnani FR,

Moghimi SM, Genetically engineered T cells bearing chimeric nanoconstructed receptors

harboring TAG-72-specific camelid single domain antibodies as targeting agents, Cancer Letters,

2013, 334(2): 237-244.

3- Sharifzadeh Z, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudid F, Jamnani FR,

Development of Oligoclonal Nanobodies for Targeting the Tumor-associated Glycoprotein 72

Antigen, Molecular biotechnology, 2013, 54(2): 590-601.

4- Jamnani FR, Rahbarizadeh F, Shokrgozar MA, Ahmadvand D, Mahboudid F, Sharifzadeh Z,

Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing

tumor cells, Experimental Cell Research, 2012, 318(10): 1112-24.

5- Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z. Nanobody, an Old Concept and New Vahicle

for Immunotargeting, Immunological Investigations, 2011; 40(3):299-338.

6- Safarian F, Rahbarizadeh F, Amanpour S, Sharifzadeh Z. Construction of PEG-PAMAM

dendrimer-based TAG72-targeting nanocarrier for t-Bid gene delivery to colorectal tumor cells.

Modares Journal of Medical Sciences: Pathobiology, 2011; 14: 63-74.

7- Foroumadi A, Sakhteman A, Sharifzadeh Z, Mohammadhosseini N, Hemmateenejad B,

Moshafi MH, Vosooghi M, Amini M, Shafiee A. Synthesis, antituberculosis activity and QSAR

study of some novel 2-(nitroaryl)-5-(nitrobenzylsulfinyl and sulfonyl)-1,3,4-thiadiazole

derivatives, DARU, 2007; 15(4): 218-226.

8- Foroumadi A, Kargar Z, Sakhteman A, Sharifzadeh Z, Feyzmohammadi R, Kazemi M,

Shafiee A. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl) -1,3,4-thiadiazol-

2-ylthio]propionates, Bioorganic & Medicinal Chemistry Letters, 2006; 16: 1164–1167.

Congress Abstracts:

1- Sharifzadeh Z, Abolhassani M, Yasemi M, Construction of a scFv phage display library

PUBLICATIONS:

1. Kiaei MM, Kargar R, Niknam HM (1991) The influence of the route of administration of Newcastle disease vaccine on immunity of cage reared broiler chickens. The Scientific Journal of Agriculture (Shahid Chamran University) 14(1&2): 4-5.
2. Mahmoudzadeh-Niknam H, Mansoori P, Nikbin B, Daneshpajouh M, Amirkhani A, Alimohammadian MH, (1996) HLA class I in Iranian psoriatic patients. Medical Journal of Islamic Republic of Iran 10(1):34-41.
3. Mahmoudzadeh-Niknam H, Alimohammadian MH, Nasaft S, Amirkhani A (1996) Effect of mammalian ambient temperature onLeishmania majorpromastigote: viability, morphology, and immunogenicity in BALB/c mice. Iranian Journal of Medical Sciences 21(3&4): 125-129.
4. Mahmoudzadeh-Niknam H, Khalili Gh, Nikbakht-Dehkordi A, Alimohammadian MH, Nikbin-Moghadam B (2001) Advantages of placenta as a source for mass production of HLA-antisera. Iranian Biomedical Journal 5(1): 53.
5. Shokrgozar MA, Mahmoudzadeh-Niknam H, Shokri F (2002) Distribution of circulating immune cells in responder and non-responder individuals to Hepatitis B vaccine. Iranian Biomedical Journal 6(1): 1-5.
6. Mahmoudzadeh-Niknam H, Khalili G, Fadavi P (2003) Allelic distribution of human leukocyte antigen in Iranian patients with pulmonary tuberculosis. Human Immunology 64(1): 124-9.
7. Mahmoudzadeh-Niknam H, McKerrow JH. Leishmania tropica: cysteine proteases are essential for growth and pathogenicity. Exp Parasitol. 2004 Mar-Apr; 106(3-4):158-63.
8. Mahmoudzadeh-Niknam H. (2004) Induction of partial protection against Leishmania major in BALB/c mice by Leishmania tropica.  Scand J Lab Anim Sci. 31(4): 201-207.
9. Partovi F., Khalili G., Kariminia A., Mahmoudzadeh-Niknam H. (2007) Effect of Giradia lamblia infection on the cognitive function of school children. Iranian Journal of Public Health 36(1):73-78.
10. Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. (2007) Leishmaniatropicainfection, in comparison toLeishmania major, induces lower delayed type hypersensitivity in BALB/c mice. Korean J Parasitol. 45(2):103-109.
11. Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. (2007) Viscerotropic growth pattern ofLeishmania tropicain BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis. Korean J Parasitol. 45(4):247-53.
12. Alimohammadian MH, Darabi H, Malekzadeh S, Mahmoodzadeh-Niknam H, Ajdary S, Khamesipour A, Bahonar A, Mofarrah A. (2007) Exposure toLeishmania majormodulates the proportion of CD4+ T cells without affecting cellular immune responses. Microbiol Immunol. 51(10):1003-11.
13. Arasteh J, Pourpak Z, Ebtekar M, Pourfathollah AA, Hassan ZM, Farahmandian T, Mahmoudzadeh-Niknam H. (2010) Evaluation of the Effect of IL-22 on Human Cord Blood CD4+ T Cells. Iran J Allergy Asthma Immunol. 9(2):59-67.
14. Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M, Moradi M, Alimohammadian MH, Parviz P. (2010) Complete conservation of an immunogenic gene (lcr1) in Leishmania infantum and Leishmania chagasi isolated from Iran, Spain and Brazil. J Vector Borne Dis. 47(4):204-10.
15. Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D. (2011) Protective immunity againstLeishmania majorinduced byLeishmania tropicainfection of BALB/c mice. Exp Parasitol, 127(2):448–453.
16. Mahmoudzadeh-Niknam H, Abrishami F, Doroudian M, Moradi M, Alimohammadian MH, Parvizi P, Hatam GR, Mohebali M, Khalaj V. (2011) The Problem of Mixing up ofLeishmaniaIsolates in the Laboratory: Suggestion of ITS1 Gene Sequencing for Verification of Species. Iran J Parasitol, 6(1):41-48.
17. Mahmoudzadeh-Niknam H, Jafari A, Abrishami F, Doroudian M, Moradi M, Kashef Bazazi B. (2011) Cloning and production of an LPS-free immunogenic protein (LCR1) from an Iranian clinical isolate ofLeishmania infantumand its recognition by sera from Iranian patients with visceral leishmaniasis.As Pac J Mo Biol Biotechnol, 19(2):95-101.
18.  Khalili G, Dobakhti F, Mahmoudzadeh Niknam H, Khaze V, Partovi F. (2011) Immunotherapy with Imiquimod Increases the Efficacy of Glucantime Therapy ofLeishmania majorInfection. Iran J Immunol, 8(1):45-51.
19. Mahmoudzadeh-Niknam H, Ajdary S, Riazi-Rad F, Mirzadegan E, Rezaeian A, Khaze V, Djadid ND, Alimohammadian MH. (2012) Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran. Trop Med Int Health, 17(11):1335-1344.
20. Mahmoudzadeh-Niknam H, Khalili G, Abrishami F, Najafy A, Khaze V. (2013) The Route ofLeishmania tropicaInfection Determines Disease Outcome and Protection againstLeishmania majorin BALB/c Mice. Korean J Parasitol, 51(1): 69-74.
21. Fadavi P, Rostamian M, Arashkia A, Shafaghi B and Niknam HM. (2013) Epstein-barr virus may not be associated with breast cancer in Iranian patients. Oncol Discov, 1:3 http://dx.doi.org/10.7243/2052-6199-1-3.
22. M Niknam H, Abrishami F, Doroudian M, Rostamian M, Moradi M, Khaze V, Iravani D. (2014) Immune Responses of Iranian Patients with Visceral Leishmaniasis and Recovered Individuals to LCR1 of Leishmania infantum. Clin Vaccine Immunol. 2014 Apr;21(4):518-25. doi: 10.1128/CVI.00711-13. Epub 2014 Feb 5.
23. Rostamian M, Sohrabi S, Kavosifard H, Niknam HM. Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice. J Microbiol Immunol Infect. 2015, in press.